Skip to content

PHARMA INSIGHT

abbreviatedPI
Absorbed by Abylsen Belgium SRL KBO/BCE: BE 0865.904.944 subsidiary of PI HOLDING

Lifetime

16 annual accounts with figures on one time axis, 20 filings since 2004
peak €9.2m (2018)
-not published
peak €1.2m (2023)
€1.2m▲ 3.5%
peak €5.8m (2023)
€5.8m▲ 25.0%
€2.3m▼ 34.3%
peak 162.8 FTE (2022)
141.7 FTE▼ 13.0%
Board2 names since 2021
1 directorGo Sense
Owners
  
Documentsfilings and deeds
08-07-202423 days before the deadline
2023financial year
Turnover from €15.2m to €17.0mStaff from 162.8 FTE to 141.7 FTEEquity from €4.6m to €5.8mDebts from €3.5m to €2.3m

Key points

from the 2023 annual accounts, the last ones filed

Payment terms

53 days to suppliers
Suppliers
126 to 53
Customers
86 to 100

PHARMA INSIGHT pays its suppliers 73 days earlier than in 2022. Customers pay 14 days later.

Liquidity

3.46 was 2.28 in 2022

Short-term debts fell from €3.5m to €2.3m.

Filings

20 annual accounts since 2004
AprilJune31 JulyOctober2005201020152020

Four of the last ten came late. The 2016 accounts came latest: 77 days after the end of the period.

No score

Board and ownership

GS
Director, Vera Goossens, since 01-08-2021
CV
Auditor, Mathias Roef
  • PI HOLDING 100%equity €8.2m (2023) · deed of 22-05-2024
Board & ownership

Recent changes

Merger: absorbed by ABYLSEN BELGIUM General meeting of 27-06-2024 · Gazette deed
Merger proposal: to be absorbed by Abylsen Belgium SRL Abylsen Belgium SRL holds all the shares · Newco Belgatech SA holds all the shares · EuroTech SA holds 100% of the shares · Gazette deed
Appointment: Go Sense (director) Permanent representative: Vera Goossens · General meeting of 01-08-2021 · Gazette deed
Registered office moved within Ghent New registered office: Ottergemsesteenweg-Zuid 808 bus B166 te 9000 Gent · Previous registered office: Rijvisschestraat 124, 9052 Gent · Reappointment: Vandelanotte Bedrijfsrevisoren CVBA (statutory auditor) · Board meeting of 07-07-2021 · Gazette deed
All 33 events

Official details

Source: KBO
Status
Absorbed by Abylsen Belgium SRLmerger by absorption, July 2024
Activity
“De consultancy in de farmaceutische, gezondheids-, informatietechnologie- en engineeringsector” (deed in Dutch)From the articles, 28 activitiesNo NACE code in the KBO yet
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2023

€8.1m▼ 0.6%
Filing
Filed on 08-07-2024
Financials

Companies linked to PHARMA INSIGHT

Insights on PHARMA INSIGHT

Absorbed by Abylsen Belgium SRL in July 2024. The last annual accounts are for financial year 2023.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMA INSIGHT

What is the company number of PHARMA INSIGHT?
The company number of PHARMA INSIGHT is 0865.904.944. The VAT number is the same number with BE in front: BE 0865.904.944.
What is the legal form of PHARMA INSIGHT?
Legal form of PHARMA INSIGHT: BV.
Is PHARMA INSIGHT still active?
No. PHARMA INSIGHT is inactive in the KBO register.Company details
How many employees did PHARMA INSIGHT have?
PHARMA INSIGHT had an average of 141.7 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
What is the turnover of PHARMA INSIGHT?
The turnover of PHARMA INSIGHT was €17.0m in financial year 2023, according to the filed annual accounts.
Is PHARMA INSIGHT profitable?
In financial year 2023, PHARMA INSIGHT made a profit of €1.2m.
Where can I find the annual accounts of PHARMA INSIGHT?
PHARMA INSIGHT filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2023.

Next steps

Keep this company with today's facts in a case file.